Neil Dahiya

Cencora Introduces Accelerate Pharmacy Solutions to Strengthen Hospital and Health System Customer Support

Cencora, an international leader in healthcare solutions, recently revealed the launch of Accelerate Pharmacy Solutions, a comprehensive suite aimed at assisting hospital and health system clients in optimizing their operations and boosting fiscal performance. Accelerate Pharmacy Solutions consolidates Cencora’s range

Cencora Introduces Accelerate Pharmacy Solutions to Strengthen Hospital and Health System Customer Support Read More »

Innate Pharma and IFLI Partner to Launch Clinical Study on IPH6501’s Role in Treating Follicular Lymphoma

Innate Pharma S.A., a globally recognized biotechnology firm at the clinical stage, has formed a partnership with the Institute for Follicular Lymphoma (IFLI), a prominent international non-profit organization, to explore the clinical potential of IPH6501, Innate’s anti-CD20 ANKET, in addressing

Innate Pharma and IFLI Partner to Launch Clinical Study on IPH6501’s Role in Treating Follicular Lymphoma Read More »

Max Foundation Broadens Collaboration with Novartis to Enhance Access to Breakthrough Therapy for Paroxysmal Nocturnal Hemoglobinuria

The Max Foundation, an international nonprofit focused on advancing health equity, is set to expand its partnership with Novartis to include the innovative treatment Fabhalta (iptacopan) for paroxysmal nocturnal hemoglobinuria (PNH) in low-resource regions. This development aims to provide cutting-edge

Max Foundation Broadens Collaboration with Novartis to Enhance Access to Breakthrough Therapy for Paroxysmal Nocturnal Hemoglobinuria Read More »